Transmissible Viral Vaccines

Slides:



Advertisements
Similar presentations
Multipurpose prevention technologies: the future of HIV and STI protection José A. Fernández-Romero, Carolyn Deal, Betsy C. Herold, John Schiller, Dorothy.
Advertisements

Gene Ontology and the annotation of pathogen genomes: the case of Candida albicans Martha B. Arnaud, Maria C. Costanzo, Prachi Shah, Marek S. Skrzypek,
Multifaceted roles for lipids in viral infection Nicholas S. Heaton, Glenn Randall Trends in Microbiology Volume 19, Issue 7, Pages (July 2011)
Structure and Activity of Strigolactones: New Plant Hormones with a Rich Future Binne Zwanenburg, Tomáš Pospíšil Molecular Plant Volume 6, Issue 1, Pages.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Vaccines for the elderly
International Journal of Infectious Diseases
Global warming and sexual plant reproduction
Valerie Le Sage, Alessandro Cinti, Andrew J. Mouland 
Predicting Vaccine Responsiveness
Pathogen Recognition: TLRs Throw Us a Curve
Treatment, promotion, commotion: antibiotic alternatives in food-producing animals  Heather K. Allen, Uri Y. Levine, Torey Looft, Meggan Bandrick, Thomas.
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections  Craig Winstanley, Siobhan O’Brien, Michael.
Influenza Vaccines: Challenges and Solutions
Harnessing the Potential of the Tea Tree Genome
Human Diallelic Insertion/Deletion Polymorphisms
The microarray technology: facts and controversies
Filip Van Immerseel, Julian I. Rood, Robert J. Moore, Richard W
The Interfaces of Genetic Conflict Are Hot Spots for Innovation
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Evolving Gene Therapy in Primary Immunodeficiency
Sam Afkhami, Yushi Yao, Zhou Xing 
Critical research concepts in tuberculosis vaccine development
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections  Craig Winstanley, Siobhan O’Brien, Michael.
Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention  Scott C. Weaver  Trends in Microbiology 
Microbiology Managers: Managerial Training in the RItrain Project
God's Gift to Women: The Human Papillomavirus Vaccine
Applying the Brakes: When to Stop Eating
Damjan S. Nikolic, Vincent Piguet  Journal of Investigative Dermatology 
P.L. Lopalco, P. Carrillo Santisteve 
The emergence of mecC methicillin-resistant Staphylococcus aureus
Trends in Microbiology
Epidemiology of opportunistic infections in AIDS patients
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
Volume 152, Issue 1, (January 2013)
Accelerating cervical cancer control and prevention
Stable-Isotope Probing of Human and Animal Microbiome Function
Dengue Antibody and Zika: Friend or Foe?
Symposia and Oral Presentations
Victor S. Pylro, Tsai S. Mui, Jorge L. M. Rodrigues, Fernando D
Plasma Cells for Hire: Prior Experience Required
Jeffrey A. Fawcett, Hideki Innan  Trends in Genetics 
Immunological Synapse: Center of Attention Again
Community-acquired pneumonia: epidemiologic and clinical consideration
Eva Guinan, Leo Luzmik, Rupert Handgretinger, Ann Woolfrey 
Evolution of Salmonella within Hosts
Evolutionary Immunology: A boost to immunity from nurse sharks
Vaccines for the elderly
A Sequencing-Based Linkage Map of Cucumber
From “A”IV to “Z”IKV: Attacks from Emerging and Re-emerging Pathogens
Zika Virus: Two or Three Lineages?
Alistair J.P. Brown, Gordon D. Brown, Mihai G. Netea, Neil A.R. Gow 
Katrina A. Lythgoe, Andy Gardner, Oliver G. Pybus, Joe Grove 
Table of contents The Journal for Nurse Practitioners
Ubiquitin Makes Its Mark on Immune Regulation
Immunologic Basis of Vaccine Vectors
Inflaming the CD8+ T Cell Response
Urbanization and geographic expansion of zoonotic arboviral diseases: mechanisms and potential strategies for prevention  Scott C. Weaver  Trends in Microbiology 
Cross-modal impacts of anthropogenic noise on information use
Treatment, promotion, commotion: antibiotic alternatives in food-producing animals  Heather K. Allen, Uri Y. Levine, Torey Looft, Meggan Bandrick, Thomas.
Sam Afkhami, Yushi Yao, Zhou Xing 
The Danish Renal Biopsy Register
Crossing the Rubicon: New Roads Lead to Host Defense
Lung Density in Extremely Large Healthy Lungs
Broadening Horizons: New Antibodies Against Influenza
Muriel Derrien, Johan E.T. van Hylckama Vlieg  Trends in Microbiology 
T Cells Take on Zika Virus
Hannah R. Elliott, David C. Samuels, James A. Eden, Caroline L
Volume 148, Issue 1, (January 2012)
Presentation transcript:

Transmissible Viral Vaccines James J. Bull, Mark W. Smithson, Scott L. Nuismer  Trends in Microbiology  Volume 26, Issue 1, Pages 6-15 (January 2018) DOI: 10.1016/j.tim.2017.09.007 Copyright © 2017 The Authors Terms and Conditions

Figure 1 KeyFigure: Basic Epidemiological Properties of Transmissible Vaccines Each row represents a population at a point in time. Time flows down. Gray circles are individuals with the vaccine, open circles are susceptible. Arrows represent transmission of the vaccine from one individual to another. Directly vaccinated individuals are those with no arrow leading into them. (A) A weakly transmissible vaccine. Direct vaccination occurs in the first time interval shown, and the vaccine quickly dies out. (B) A highly transmissible vaccine; the vaccine spreads. (C) A weakly transmissible vaccine in which direct vaccination continues throughout the time shown. Although chains of transmission are short, they increase the number of vaccinated individuals within the population. Trends in Microbiology 2018 26, 6-15DOI: (10.1016/j.tim.2017.09.007) Copyright © 2017 The Authors Terms and Conditions

Figure 2 A Transmissible Vaccine That Occasionally Reverts to Its Wild-Type State. (A) A weakly transmissible attenuated vaccine that reverts. The revertants (red) have high transmissibility, but are suppressed by ongoing vaccination. (B) A highly transmissible recombinant vector vaccine that reverts – loses its antigenic insert (blue). Revertants are also blocked by ongoing vaccination, provided the complete vaccine elicits immunity against both the pathogen and vector. Trends in Microbiology 2018 26, 6-15DOI: (10.1016/j.tim.2017.09.007) Copyright © 2017 The Authors Terms and Conditions